News

MongoDB Reports Impressive Q2 Results and Customer Growth

MongoDB Reports Impressive Q2 Results and Customer Growth

MongoDB, Inc. Financial Highlights for Q2 Fiscal 2026

Total Revenue: MongoDB, Inc. achieved a total revenue of $591.4 million for Q2 fiscal 2026, marking a remarkable 24% growth compared to the previous year. This increase highlights MongoDB's robust market position and the growing demand for its services.

MongoDB Atlas Performance

The revenue generated from MongoDB Atlas surged by 29% year-over-year, accounting for an impressive 74% of the total revenue for the quarter. This substantial growth is indicative of the rising preference among businesses for cloud-based database solutions that offer flexibility and scalability.

Customer Growth

MongoDB experienced a significant expansion in its customer base, adding 2,800 new customers during this quarter. The total customer count now exceeds 59,900, showcasing MongoDB's influence and reach across various sectors.

Financial Results Overview

The financial results for the second quarter of fiscal 2026 are as follows:

  • Revenue: $591.4 million (24% increase year-over-year)
  • Subscription Revenue: $572.4 million (23% increase year-over-year)
  • Services Revenue: $19.0 million (33% increase year-over-year)
  • Gross Profit: $420.0 million, resulting in a gross margin of 71%
  • Net Loss: $47.0 million or $0.58 per share
  • Free Cash Flow: $69.9 million, a significant recovery from the negative cash flow reported last year.

Management Insights

Dev Ittycheria, President and CEO, expressed pride in the company's performance, stating, "We achieved significant revenue growth and customer acquisition in the second quarter. Our ability to exceed expectations on both the top and bottom line motivates us to maintain a forward momentum for the remainder of the fiscal year."

Innovations and Strategic Moves

In line with the strong financial results, MongoDB is also focusing on innovation. This quarter saw the introduction of new AI-driven products and expanded partnerships with major players in the AI field. The company is committed to enhancing its services and versatility in meeting the needs of AI applications, demonstrating the adaptability and future-oriented nature of its offerings.

Forward Guidance

Looking forward, MongoDB provided encouraging guidance for the third quarter and the full fiscal year. The company anticipates revenues between $587 million and $592 million for Q3, and total revenues for the year are expected to be in the range of $2.34 billion to $2.36 billion. This outlook reflects MongoDB's confidence in sustaining its growth trajectory and fulfilling customer demands.

Conference Call and Investor Engagement

MongoDB is committed to transparency and communication with its investors. The company recently hosted a conference call to discuss its Q2 financial results and strategic direction moving forward. The insights provided in these discussions offer invaluable information about MongoDB's plans and operational strategies.

Frequently Asked Questions

1. What were MongoDB's total revenues for Q2 fiscal 2026?

Total revenues for Q2 fiscal 2026 amounted to $591.4 million, reflecting a 24% year-over-year growth.

2. How much did MongoDB Atlas generate in revenue?

MongoDB Atlas generated $572.4 million in revenue, representing a 29% increase compared to the previous year.

3. What is MongoDB's customer growth for the quarter?

MongoDB added 2,800 new customers this quarter, bringing the total customer count to over 59,900.

4. What is the outlook for future revenues?

MongoDB anticipates revenues between $587 million and $592 million for Q3 and total revenues of $2.34 billion to $2.36 billion for the full year.

5. Who is the CEO of MongoDB?

The CEO of MongoDB is Dev Ittycheria, who has been instrumental in leading the company through significant growth and innovation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 37

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 40

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 52

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 46

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 63

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 35

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

NORBIT Secures Significant NOK 120M Defence Order

Updated Category News Views 288

NORBIT Secures Significant NOK 120 Million Defence Order NORBIT has recently made an exciting announcement regarding a significant contract within its segment PIR. The company has been awarded a manufacturing order valued at NOK 120 million from a European client specializing in defence and security. This order is poised for delivery in late 2025 and early 2026, marking a...

Continue Reading
Shareholder Concerns Over BCO, SEM, NATL Transactions

Updated Category News Views 12

Is There Smoke Without Fire in Recent Company Mergers? Well, here we go again. It seems every time deals like these pop up, questions start flying about fairness and insider scoops. The big fish here? The Brink's Company (NYSE:BCO), Select Medical Holdings Corporation (NYSE:SEM), and NCR Atleos Corporation (NYSE:NATL). Halper Sadeh LLC, the investor rights firm, is on a...

Continue Reading
TG Therapeutics Director’s Recent Stock Sale Raises Questions

Updated Category News Views 120

Significant Insider Transaction at TG Therapeutics Recently, an important transaction came to light involving Yann Echelard, Director at TG Therapeutics (NASDAQ:TGTX). The details were revealed through the latest SEC filing. On a given date, Echelard sold 5,000 shares, raising a total of $162,850. Such insider trading can often prompt discussions regarding the company’s...

Continue Reading
Innovative Leadership in Facilities Management Revolutionized

Updated Category News Views 214

MasonMade Ventures Launches to Revamp Facilities Management Serial Entrepreneurs Aim to Disrupt the FM Industry through Innovative Software Solutions and Expert Trades MasonMade Ventures, established by visionary entrepreneurs Joseph Scaretta and Moses Carrasco, is set to change the face of facilities management. This operational holding company focuses on investing in...

Continue Reading
Kyverna Therapeutics Engages Investors at Upcoming Events

Updated Category News Views 136

Kyverna Therapeutics' Upcoming Investor Conferences Kyverna Therapeutics, Inc. (NASDAQ: KYTX), a pioneering clinical-stage biopharmaceutical company committed to innovative cell therapies for autoimmune diseases, is slated to present at a series of significant investor conferences this September. Warner Biddle, the Chief Executive Officer of Kyverna, will be the...

Continue Reading